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Bornaviruses are nonsegmented negative-strand RNA viruses that establish a persistent 2 
infection in the nucleus and integrate occasionally a DNA genome copy into the host 3 
chromosomal DNA. However, how these viruses achieve intranuclear infection remains 4 
unclear. We show that Borna disease virus (BDV), a mammalian bornavirus, closely 5 
associates with the cellular chromosome to ensure intranuclear infection. BDV generates viral 6 
factories within the nucleus using host chromatin as a scaffold. In addition, the viral 7 
ribonucleoprotein (RNP) interacts directly with the host chromosome throughout the cell 8 
cycle, using core histones as a docking platform. HMGB1, a host chromatin-remodeling DNA 9 
architectural protein, is required to stabilize RNP on chromosomes and for efficient BDV 10 
RNA transcription in the nucleus. During metaphase, the association of RNP with mitotic 11 
chromosomes allows the viral RNA to segregate into daughter cells and ensure persistent 12 
infection. Thus, bornaviruses likely evolved a chromosome-dependent lifecycle to achieve 13 
stable intranuclear infection.14 
 3 
INTRODUCTION 1 
The cell nucleus is a dynamic organelle that may be considered an inconvenient site for virus 2 
infection. Dissolution of the nuclear membrane during mitosis and nucleocytoplasmic 3 
trafficking through nuclear pores could lead to the loss or dilution of viral genomes from the 4 
nucleus. Alteration of the intranuclear environment by gene expression may also affect virus 5 
stability. For persistent DNA viruses, such as gammaherpesviruses and papillomaviruses, 6 
association of a low copy number of viral episomal DNA with cellular chromosomes ensures 7 
their stable retention over long periods of time in such a dynamic environment (Ballestas et al., 8 
1999; Feeney and Parish, 2009; Lehman and Botchan, 1998; Piolot et al., 2001). Residence in 9 
the nucleus, however, would not be an easy task for other types of viruses, in particular 10 
viruses using RNA as the template for replication.  11 
Among vertebrate RNA viruses, except for the reverse-transcribing retroviruses, only 12 
two families, Bornaviridae and Orthomyxoviridae, enter the nucleus for replication and 13 
transcription. However, there is a fundamental difference between these two viruses. 14 
Bornaviruses replicate non-cytopathically and readily establish a long-lasting, persistent 15 
infection in the nuclei of cultured cells and various tissues (Schneider et al., 2007; Tomonaga 16 
et al., 2002), whereas a consequence of infection by influenza virus, belonging to the 17 
Orthomyxoviridae, is induction of apoptotic cell death. Thus, bornaviruses are the only known 18 
RNA viruses that can parasitize within the nuclear membrane.  19 
Borna disease virus (BDV) is the prototype bornavirus and is known to infect many 20 
mammalian species (Schneider, 2005; Staeheli et al., 2000). A unique feature of BDV is that 21 
only a small number of infectious particles are released from infected cells (Gonzalez-Dunia 22 
 4 
et al., 1997; Tomonaga et al., 2002). Nevertheless, the copy number of the viral genomic RNA 1 
(vRNA) is maintained during the persistence of BDV in the nucleus. Recently, we have 2 
reported that BDV generates DNA forms of its own mRNA in infected cells, and integrates 3 
DNA copies of the nucleoprotein (N) mRNA into the host genome (Horie et al., 2010). 4 
Furthermore, we found that bornaviruses have left their own endogenous elements in the 5 
genomes of several animal species, including humans, non-human primates and rodents, as a 6 
“fossil record” of ancient bornavirus infection (Belyi et al., 2010; Horie et al., 2010). 7 
However, the fundamental question of how bornaviruses can achieve such a stable 8 
intranuclear infection has not been elucidated. 9 
In this study, we analyzed in detail the intranuclear dynamics of BDV to understand the 10 
unique life cycle of bornavirus in the nucleus. We showed that BDV generates spheroidal 11 
viral factories in the nucleus, using chromatin environments as a scaffold for the structure. In 12 
addition, the BDV ribonucleoprotein (RNP) was seen to be tightly associated with condensed 13 
chromosomes upon mitosis and to segregate into daughter cell nuclei along with mitotic 14 
chromosomes. Immunoprecipitation analysis of the chromatin-binding fraction revealed that 15 
core histones are the docking partners of viral RNP to chromatin. Furthermore, we showed 16 
that the chromatin-remodeling, DNA-binding protein, HMGB1 (high mobility group box 17 
protein 1) may be involved in the transcription and stability of BDV on chromatin by 18 
increasing the stability of the viral phosphoprotein (P) on chromatin-bound RNP. Our results 19 
show that bornaviruses establish a life cycle highly associated with the cellular chromosome 20 
and take advantage of chromosomal stability and dynamics to ensure the integrity of its RNP 21 
in the infected nucleus, presenting an alternative fashion of infection by non-reverse 22 
 5 
transcribing RNA viruses in eukaryotic cells. 1 
 2 
RESULTS 3 
BDV generates viral factories associated with chromatin structures.  4 
To determine how bornaviruses establish stable infection in the nucleus, we first examined the 5 
intranuclear distribution of BDV in infected human oligodendroglioma (OL) cells. We 6 
performed immunofluorescence analysis (IFA) using antibodies to BDV N and P, both of 7 
which are major components of the viral RNP. The viral nucleocapsid is composed of the 8 
vRNA tightly encapsidated by N to form the RNP, which serves as the template for replication 9 
by the viral polymerase complex, including P (Hock et al., 2010; Schwemmle et al., 1998). 10 
IFA showed that BDV N and P colocalize in subnuclear dots, which are usually multiple and 11 
variable in size, in the interphase nuclei (Figure 1A). These nuclear dots were seen in almost 12 
all infected cells and no known nuclear speckles were found to colocalize with these viral dots 13 
(data not shown). Each RNP component alone appears insufficient to assemble such nuclear 14 
aggregates (data not shown). Confocal microscope images show that the viral speckles, 15 
including granular dots (arrowheads), are localized in contact with the borders of 16 
heterochromatin stained by 4’,6’-diamidino-2-phenylindole (DAPI) (Figure 1A, insets). 17 
Detailed observation with a higher magnification showed that the larger dots form a 18 
ring-shaped structure, which may be seen as a hollow spheroid using maximum z projections 19 
of vertical slices of confocal images (Figure 1B). The intensity profile indicated that the 20 
spheroidal body interacts with heterochromatin, mostly at the termini of the structures (Figure 21 
1B). Fluorescence in situ hybridization (FISH) using BDV-specific riboprobes showed that 22 
 6 
both sense and antisense viral RNAs generate the dot-like and granular speckles in association 1 
with DAPI staining in the nucleus (Figure 1C). Interestingly, FISH combined with IFA using 2 
anti-N antibody showed that riboprobes hybridized mostly in the cavities of the spheroids 3 
(Figure 1D). Considering that the encapsidated vRNA could not be hybridized by riboprobes, 4 
the non-encapsidated and/or the nascent vRNA might be inside the cavity. These observations 5 
support earlier suggestions (Chase et al., 2007; Schneider et al., 2003) that the BDV-specific 6 
dot structure may be a viral factory, in which essential events of the viral replication cycle 7 
take place. Furthermore, the viral dot structure may be also unique as a subnuclear speckle, in 8 
which RNA transcription may occur, and therefore we called them vSPOT (viral speckle of 9 
transcripts). 10 
To further investigate the detailed distribution and ultrastructure of vSPOT in the 11 
nucleus, we performed correlative fluorescence microscopy-electron microscopy (FM-EM) 12 
and immuno-EM analyses. The correlative FM-EM technique allowed us to determine the 13 
localization of viral factories by both FM and EM in the same samples. BDV-infected cells 14 
were stained with anti-N antibody and DAPI and examined under FM, and the same fields 15 
were observed under EM. As shown in Figures 2A and S1A, in interphase cells, vSPOT was 16 
observed as a highly electron-dense, spherical aggregate without a membrane, which often 17 
contained a low density cavity in the center (Panel 2). The high magnification images showed 18 
that vSPOT is composed of a complex of twisted filamentous structures, which often show 19 
helical shapes (Panel 3, arrows) and seem to be connected to the surrounding chromatin 20 
structures, such as highly electron-dense heterochromatin (Panel 2, arrowheads), directly or 21 
by thin fibrils (Panel 4, arrows). Serial section analysis showed that heterochromatin 22 
 7 
territories are closely associated with vSPOT (Figure 2B, arrowheads). Furthermore, 1 
immuno-EM analysis using anti-N antibody revealed that the signals of N are mainly found at 2 
the rim of vSPOT (Figures 2C and S1B) and also can be detected in close contact with 3 
heterochromatin as small aggregates (Figure 2D, arrow). These observations were consistent 4 
with the immunofluorescence images shown in Figure 1 and indicated that BDV may use the 5 
chromatin structure as a scaffold for assembly of viral factories in the interphase nuclei. 6 
 7 
BDV RNP is tethered to mitotic chromosomes.  8 
BDV can persistently infect not only non-dividing neurons but also dividing cells (Brnic et al., 9 
2012; Okamoto et al., 2003), and previous reports suggested chromatin-association of BDV 10 
(Suberbielle et al., 2008; Tomonaga, 2007). Thus, we next investigated in detail the 11 
localization of BDV RNP during the phases of mitosis by both IFA and EM analysis. During 12 
the metaphase stage of mitosis, in which the nuclear membrane breaks down and the 13 
chromosomes are highly condensed in the center of cells, vSPOTs disappeared and the RNP 14 
proteins seemed to be widely dispersed on the surfaces of the condensed chromosomes 15 
(Figures 3 and S2A). The maximum z projections of vertical slices of confocal images 16 
revealed that small granules were tethered to the metaphase chromosome. Furthermore, 17 
during anaphase and telophase, in which the divided chromosomes move apart toward the 18 
poles of the spindle, the fluorescence was shown to associate mostly with the separating 19 
chromosomes (Figures 3 and S2A). Recombinant N labeled with fluorescent proteins also 20 
localized to mitotic chromosomes in the living infected cells (Figure S2B), suggesting that the 21 
interaction between BDV proteins and mitotic chromosomes is not an artifact generated by 22 
 8 
cell fixation. Furthermore, we also observed distribution of vRNA on mitotic chromosomes 1 
by FISH. The fluorescence for vRNA was clearly detected on metaphase chromosomes of 2 
BDV-infected cells, although the signal appeared to be weak, probably due to the tight 3 
encapsidation of vRNA on mitotic chromosomes (Figure 3B).  4 
We also performed correlative FM-EM analysis using the metaphase and anaphase 5 
stages of BDV-infected cells. During metaphase, fluorescence clearly corresponded to the 6 
highly electron-dense structures, which could be seen as tangles of coiled electron-dense 7 
threads (Figure 4A, panels 1 and 2). The structures seemed to be tethered to the metaphase 8 
chromatin by a thin network of chromatin fibrils (Figure 4A, panels a to d). Serial sectioning 9 
revealed that the highly electron-dense tangles are spherically shaped with a diameter of less 10 
than 500 nm, suggesting that they may consist of only a small number of RNPs (Figure S3). 11 
The immune-EM analysis revealed that anti-N antibody reacted with the tangles on the 12 
condensed chromatin of metaphase cells (Figure 4B). In anaphase cells, although the 13 
fluorescence seemed to correspond to highly electron-dense aggregates on the separating 14 
chromosomes (Figure 4C, arrowheads), an RNP-like structure, which can be obviously 15 
distinguished from the condensed chromosomes, was not seen by correlative FM-EM analysis. 16 
On the other hand, the immune-EM analysis clearly showed that N was dispersed on the 17 
telophase chromosomes (Figure 4D). All these results suggest that BDV interacts directly 18 
with mitotic chromosomes and is segregated into the daughter cell nuclei along with the 19 
separating chromosomes, which might ensure the continued intranuclear residence of BDV 20 
during persistent infection. 21 
 22 
 9 
Replication-competent BDV RNP associates with the host chromosome.  1 
By microscopic analyses, we showed that BDV RNP components associate with the host 2 
chromosome throughout the cell cycle. On the other hand, it is still not clear whether the 3 
fluorescence on chromatin consists of infectious BDV RNP. To determine whether BDV 4 
actually interacts with chromatin as an RNP, we first carried out a chromatin-binding assay 5 
using both asynchronous and metaphase-arrested BDV-infected OL cells. We isolated 6 
chromatin fractions from the same numbers of asynchronous and metaphase cells and released 7 
chromatin-bound factors using micrococcal nuclease (MNase). As shown in Figure 5A, the 8 
MNase-resistant encapsidated vRNA, as well as BDV N and P, was detected at a similar level 9 
in the chromatin-binding fraction from both asynchronous and metaphase-arrested cells. 10 
Considering that P stably associates with chromatin only via interaction with N (Figure 5B), 11 
this result indicated that BDV interacts with chromatin as a form of RNP containing P. 12 
Furthermore, the fact that the asynchronous culture contains less than 10% mitotic cells 13 
suggests that relatively the same amount of RNP is associated with chromatin, regardless of 14 
the stage of the cell cycle. Salt-extraction of chromatin-associated proteins indicated that RNP 15 
components are released from chromatin with similar kinetics and are mostly extracted by 16 
200 mM salt (Figure S4A), indicating a tight affinity of RNP for cellular chromatin. Moreover, 17 
we also found that transfection of the chromatin-binding fraction from both asynchronous and 18 
metaphase-arrested BDV-infected OL cells into uninfected cells led to viral replication 19 
(Figure 5C). All these data indicated that replication-competent BDV RNP is associated with 20 
the cellular chromosome throughout the cell cycle. 21 
 22 
 10 
BDV RNP interacts with chromatin via core histones.  1 
We sought next to determine the binding partner of N on chromatin by an 2 
immunoprecipitation assay using BDV-infected OL cells transfected with 3 
tandem-affinity-purification-tagged N (TAP-N). SDS-PAGE followed by mass spectrometry 4 
revealed that TAP-N interacts with poly(adenosine diphosphate-ribose) polymerase 1 5 
(PARP-1), a nucleosome binding, non-histone protein, as well as core histones (Figure S4B). 6 
The specificity of the analysis was verified by western blotting (Figure S4C). Unexpectedly, 7 
these proteins could not be precipitated from uninfected cells transfected with TAP-N only. As 8 
shown in Figure 5B, the chromatin-binding ability of TAP-N seems to be markedly low when 9 
compared with wild-type N, suggesting that the TAP-tag may interfere with the direct binding 10 
of the fusion protein to chromatin. On the other hand, TAP-N may be able to associate with 11 
chromatin by being incorporated into the viral nucleocapsid in infected cells. The interaction 12 
of viral RNP with core histones was confirmed by immunoprecipitation analysis using anti-N 13 
antibody. The core histones, as well as BDV P and MNase-resistant vRNA, were clearly 14 
immunoprecipitated from the chromatin-binding fractions from both asynchronous and 15 
metaphase-arrested BDV-infected cells (Figure S4D). Altogether, these results suggest that 16 
core histones may provide a platform for BDV RNP on chromatin. Note that PARP-1 17 
appeared to not colocalize with vSPOT in the infected nucleus (Figure S4E). Considering that 18 
PARP-1 is a mobile and abundant nuclear chromatin-associated protein, it might be possible 19 
that PARP-1 associates with N outside of vSPOT. 20 
 21 
HMGB1 regulates BDV RNP activity in the interphase nucleus. 22 
 11 
We investigated next how the activity of viral RNP is regulated in the nucleus. To this end, we 1 
focused on the chromatin-binding, DNA architectural protein, HMGB1, which has been 2 
demonstrated to directly bind to P (Kamitani et al., 2001; Zhang et al., 2003). BDV P is a 3 
scaffold protein for assembly of the viral polymerase complex and, therefore, HMGB1 is 4 
likely a key regulator of RNP activity. In fact, we found that HMGB1 is clearly incorporated 5 
into vSPOT in infected cells (Figure 6A). HMGB1 is a highly mobile protein in the nucleus 6 
and its mobility may be required for effective modulation of DNA structure (Bianchi and 7 
Agresti, 2005; Catez and Hock, 2009). To understand the involvement of HMGB1 in RNP 8 
activity, we first investigated the movement of HMGB1 in vSPOTs in living cells. The 9 
movement of enhanced green fluorescent protein (EGFP) fused with HMGB1 was analyzed 10 
by fluorescence recovery after photobleaching (FRAP) and fluorescence loss in 11 
photobleaching (FLIP) analyses in living BDV-infected cell nuclei. In FRAP, an area 12 
including a vSPOT was bleached and recovery of the fluorescence signal in that vSPOT was 13 
monitored. As shown in Figure 6B, fluorescence recovered rapidly in bleached vSPOTs in the 14 
nuclei of EGFP-HMGB1-transfected cells. In FLIP analysis, repeated photobleaching of 15 
vSPOTs in the nuclei of cells transfected with EGFP-HMGB1 led to an overall loss of 16 
fluorescence from the nuclei, including from unbleached vSPOTs (Figure 6B). The 17 
FRAP/FLIP analysis of EGFP-HMGB1 was also monitored in chromatin areas other than 18 
vSPOT sites in BDV-infected and uninfected nuclei, demonstrating similar movement of 19 
HMGB1 between infected and uninfected nuclei (Figure S5A). In contrast, FRAP analysis 20 
using EGFP-N-transfected, BDV-infected cells revealed that fluorescence in bleached 21 
vSPOTs only recovered to the background level during the monitoring time, indicating that 22 
 12 
EGFP-N molecules in bleached vSPOTs are not replaced by unbleached EGFP-N (Figure 6B). 1 
Furthermore, the fluorescence remained in unbleached vSPOTs during the 300 s bleaching 2 
period in cells expressing EGFP-N in FLIP (Figure. 6B, arrowhead). These observations 3 
indicated that N is considerably immobile in the vSPOT, while HMGB1 enters and leaves the 4 
vSPOTs repeatedly in a brief period.  5 
To understand the role of the interaction between BDV P and HMGB1 in the viral life 6 
cycles, we generated recombinant BDV mutants expressing BDV P variants with severely 7 
impaired HMGB1 binding activity. Alanine-scanning mutagenesis within the 8 
HMGB1-binding site of BDV P revealed that substitution of amino acid 84 reduces its 9 
efficiency to bind HMGB1 in the mammalian-two-hybrid system significantly and affects its 10 
polymerase cofactor activity in the BDV minireplicon assay (Figure S5B). Two alternative 11 
substitutions in which the glutamate residue in position 84 was substituted with either 12 
asparagine or glutamine resulted in BDV P mutants, P-E84N and P-E84Q, which failed to 13 
bind to HMGB1 efficiently, but displayed unimpaired polymerase cofactor activity. 14 
Biochemical binding assays confirmed the strongly impaired binding capacity of the two 15 
BDV P mutant proteins to HMGB1 (Figure S5C). The recombinant viruses, rBDV-E84N and 16 
rBDV-E84Q, were successfully recovered by reverse genetics technique (Figures 6D and 6E), 17 
although colocalization of HMGB1 with vSPOT was not found in cells infected with the 18 
mutant viruses (Figure 6C). It was observed, however, that the spread of both viruses was 19 
impaired and severely attenuated in OL cells (Figures S5D). Interestingly, after several 20 
passages, subsequent sequence analysis identified a lysine to glutamate exchange at position 21 
77 of P-E84N, which partially recovered its binding capacity to HMGB1 (Figure 6F). Based 22 
 13 
on these results, we speculated that the binding of HMGB1 with BDV P may be retained for 1 
efficient propagation and persistent infection in cultured cells.  2 
To understand the involvement of HMGB1 in persistent BDV infection in more detail, we 3 
generated small-interfering RNA (siRNA) and lentiviral short hairpin RNA (shRNA) vectors 4 
to knockdown the expression of HMGB1 of persistently BDV-infected cells. Because 5 
HMGB1 is an abundant nuclear protein (Catez and Hock, 2009; Stros, 2010) and it was very 6 
difficult to obtain completely knocked-down cells, we generated BDV-infected OL cells 7 
stably expressing shRNA, in which expression of HMGB1 was reduced to 70 to 90% that of 8 
normal cells (Figure S6A). The reduced levels of HMGB1 did not induce apoptotic cell death 9 
(data not shown), indicating there was no severe chromosomal instability in the knockdown 10 
cells. The structure of vSPOT appeared to be unaffected by the knockdown of HMGB1 11 
(Figure S6B). In transient HMGB1-knockdown cells, interestingly, chromatin-associated 12 
levels of P were reduced markedly, although the amount of N was comparable in control and 13 
knockdown cells (Figure 7A). The total cellular level of P, as well as N, was not changed by 14 
the knockdown of HMGB1 (Figure 7B). To rule out the possibility of an off-target effect of 15 
shRNA, we generated HMGB1-Escape, in which silent mutations were introduced into the 16 
shRNA target sequences. Expression of HMGB1-Escape, but not of a control empty plasmid, 17 
led to a recovery in the level of P on chromatin in knockdown cells (Figure 7A). The 18 
observation that P alone cannot interact with chromatin suggested that HMGB1 is involved in 19 
the interaction or stability of P in chromatin-bound RNP.  20 
To investigate whether the reduced interaction of P with RNP following 21 
HMGB1-knockdown in persistently BDV-infected cells exerts adverse effects on the 22 
 14 
persistent infection of BDV, we estimated the infection ratio, as well as transcription level, of 1 
BDV after HMGB1 knockdown in the persistently infected cells, in which infection rate was 2 
almost 100% before the knockdown. As shown in Figure 7C, the infection ratio gradually 3 
decreased in the HMGB1-knockdown cell lines. Furthermore, to understand whether 4 
HMGB1-knockdown affects BDV RNA transcription in the persistently infected cells, we 5 
determined the relative amount of BDV mRNA to vRNA. The knockdown significantly 6 
reduced the transcription level to 20 to 50% of that of the control cells during the cultured 7 
period (Figure 7D). We also confirmed that BDV polymerase activity was significantly 8 
reduced in the cells treated with siRNA for HMGB1 by the minireplicon assay (Figures S6C 9 
and S6D). 10 
We next performed a pulse-chase experiment by labeling cells with 11 
[35S]-methionine/cysteine, followed by a chase with growth medium. A chromatin-binding 12 
fraction was prepared from HMGB1-knockdown cells and immunoprecipitated with anti-N 13 
antibody. The input chromatin-binding fraction level was normalized relative to the core 14 
histones. Consistent with the above results, the RNP-associated level of P was markedly 15 
reduced in the HMGB1-knockdown cells (Figure 7E). Interestingly, the level of 16 
chromatin-bound N appeared to decrease rapidly in the knockdown cells during the chase 17 
period, whereas chromatin-bound N appeared to be relatively stable in the control cells. The 18 
half-life of chromatin-bound N was estimated to be 9.66 ± 1.34 h and 4.28 ± 0.051 h in 19 
control and knockdown cells, respectively (p <0.005) (Figure 7E), suggesting that the 20 
knockdown of HMGB1 reduces the stability of chromatin-bound RNP. Moreover, we 21 
investigated the association of BDV RNP with mitotic chromosomes of HMGB1-knockdown 22 
 15 
cells. Intriguingly, association of RNP with mitotic chromosomes was markedly abolished in 1 
the stable knockdown cells, especially in Hmg-Kd2 cells (Figures 7F, S6E and S6F). Taken 2 
together, these data strongly suggested that HMGB1 may endow the efficient transcription 3 
and stability of BDV RNP on chromatin, leading to the maintenance of the persistent infection 4 
in the nucleus. 5 
 6 
DISCUSSION 7 
This report illustrates the detailed dynamics of intranuclear infection by an RNA virus in 8 
eukaryotic cells. Our results using microscopic analyses revealed that BDV generates 9 
various-sized spheroidal aggregates containing both sense and antisense viral RNAs in the 10 
nucleus and therefore is considered to be the viral factory. The morphology and functions of 11 
the viral factories of mononegaviruses have been studied in detail for rabies virus (Lahaye et 12 
al., 2009; Menager et al., 2009). Inclusion bodies (IBs) are known to form in the cytoplasm of 13 
cells infected with rabies virus, which show similar characteristics to the Negri bodies found 14 
in the nerve cells in infected brains. Recently, Lahaye et al. (2009) demonstrated that IBs are 15 
spherical in shape and often have a cavity in the center, which contains the viral RNA. It was 16 
also shown that rabies virus IBs appear to be surrounded by N and P proteins. These 17 
morphological similarities between rabies IBs and BDV vSPOTs may represent the structural 18 
commonality of viral factories of mononegaviruses to synthesize and/or mature de novo viral 19 
RNAs. On the other hand, while rabies IBs have been shown to be associated with a double 20 
membrane in the cytoplasm, BDV vSPOTs are not segregated by a membrane structure. This 21 
difference may be attributable to how they interact with cellular factors or the 22 
 16 
microenvironment, in addition to the specificity of the replication site. In fact, EM analyses 1 
revealed that vSPOTs seem to be closely associated with chromatin structures, such as 2 
condensed heterochromatin and chromatin fibrils (Figure 2). These observations suggested a 3 
dynamic interaction between the viral factory and intranuclear factors, including chromatin 4 
environments, in the interphase nuclei.  5 
During mitosis, BDV RNP showed a unique distribution in the nucleus. At the 6 
beginning of mitosis, BDV RNP was dispersed diffusely on the condensed metaphase 7 
chromosomes (Figure 3). The EM analyses demonstrated that the RNP-like coiled structures 8 
seem to be present on the chromosomes intertwined with condensed mitotic chromatin 9 
(Figure 4). More striking was the observation that RNP is seemingly segregated into the 10 
daughter cell nuclei along with the mitotic chromosomes. The chromatin-binding assay, as 11 
well as the RNP transfection analysis, strongly supported the concept that a 12 
replication-competent BDV RNA interacts with chromatin throughout the cell cycle (Figure 13 
5). Considering that almost all cellular nuclear RNPs, including small nuclear RNPs and 14 
heterogeneous nuclear RNPs, leave the nucleus prior to mitosis and reenter the daughter cell 15 
nuclei at the end of the mitotic process (Calado and Carmo-Fonseca, 2000; Friend et al., 2008; 16 
Prasanth et al., 2003), BDV RNP may be a unique nuclear RNP that behaves like a component 17 
of cellular chromosomes in infected cells.  18 
Although BDV is known as a neurotropic virus, astrocytes can also be infected with 19 
BDV and play important roles in the viral life cycle (Carbone et al., 1991). In addition, it has 20 
recently been demonstrated that neuronal progenitor cells are also a target of BDV in the brain 21 
(Brnic et al., 2012). More importantly, vertical transmission of BDV was demonstrated in 22 
 17 
both natural and experimental infection, and BDV antigen was detected in decidual cells and 1 
endodermal cells of the infected placenta (Hagiwara et al., 2000; Okamoto et al., 2003). These 2 
observations indicated that non-neuronal and undifferentiated cells may be important targets 3 
for BDV infection. We also have recently found endogenous bornavirus elements in many 4 
mammalian genomes, suggesting that bornaviruses may infect germline cells (Horie et al., 5 
2010). Thus, the segregation of the BDV genome into daughter cell nuclei in association with 6 
mitotic chromosomes could be a highly-evolved strategy for an RNA virus to ensure spatial 7 
stability and maintain persistent residence in the nucleus. 8 
Previous studies revealed that latent DNA viruses, such as Kaposi’s sarcoma-associated 9 
herpesvirus (KSHV), Epstein-Barr virus and papillomaviruses, maintain their genomes in the 10 
nucleus as multicopy episomes tethered to host mitotic chromosomes (Ballestas et al., 1999; 11 
Feeney and Parish, 2009; Lehman and Botchan, 1998; Piolot et al., 2001) and that 12 
chromosomal proteins, including core histones, are involved in the binding of the viral DNAs 13 
with cellular chromosomes. It has been reported that KSHV’s LANA, which mediates viral 14 
episome attachment to mitotic chromosomes, directly binds to core histone H2A/2B (Barbera 15 
et al., 2006; Krithivas et al., 2002). Furthermore, papillomavirus E2 proteins have been shown 16 
to bind to Brd4, which associates with acetylated histone H4, to anchor the viral DNA to 17 
chromosome (You et al., 2004). In this study, interestingly, we also found that BDV RNP 18 
interacts with core histones and PARP-1, a non-histone, chromatin-associated protein, on 19 
chromatin. These observations imply that nucleosomes play important roles as a docking 20 
platform for the genomes of chromatin-associated viruses and that tethering viral genomes 21 
with host chromosomes could be a good way to maintain the presence of the virus within the 22 
 18 
nuclear envelope. 1 
In this study, we showed that the non-histone, DNA architectural protein, HMGB1, may 2 
affect the transcription, as well as stability, of BDV on chromatin via interaction with P 3 
(Figures 6 and 7). HMGB1 is an extremely mobile protein in the nucleus and binds to 4 
chromatin for less than a few seconds to modulate the structure of DNA (Bianchi and Agresti, 5 
2005; Catez and Hock, 2009). Furthermore, this protein has been shown to interact with many 6 
transcriptional proteins to stabilize their binding to cognate DNA sites (Muller et al., 2004). 7 
HMGB1 is known to be a multifunctional nuclear protein widely involved in the 8 
chromosomal maintenance of host cells. A well-studied nuclear factor regulated by HMGB1 9 
is the glucocorticoid receptor (GR), a transcriptional protein which binds to and releases from 10 
chromatin in cycles of only a few seconds (Agresti et al., 2005; Bianchi and Agresti, 2005). 11 
Remarkably, it is known that such a fleeting interaction is sufficient to induce large-scale 12 
remodeling of chromatin and promote transcriptional activation. HMGB1 has been shown to 13 
increase the stability of GR on the promoter sites by direct interaction with chromatin and 14 
cooperatively control the transcription activity of GR (Agresti et al., 2005). We found that 15 
HMGB1 distributes instantaneously and repeatedly to vSPOTs and then increases the 16 
association of P with RNP (Figures 6 and 7). This seems to be very similar to the regulation of 17 
GR. Given that HMGB1 can modify chromatin structure by interacting with it for less than a 18 
few seconds (Bonaldi et al., 2002; Phair et al., 2004), it is highly likely that such a brief 19 
association of HMGB1 with vSPOTs is sufficient to play a role in RNP activity on chromatin. 20 
Interaction with HMGB1 might endow the stability of P on the RNP on chromatin, resulting 21 
in efficient viral transcription. Our data using rBDVs and HMGB1-knockdown cells strongly 22 
 19 
support this hypothesis. 1 
Our study revealed that BDV is an RNA virus with a life cycle closely associated with 2 
host chromosomes. BDV may take advantage of the chromosomal stability and dynamics to 3 
ensure its own transcription and persistence in the nucleus. In fact, a previous study using a 4 
proteomic analysis has revealed that histone modifications, such as H2B acetylation on Lys-5, 5 
are found in the BDV-infected primary cortical neurons (Suberbielle et al., 2008). This finding 6 
suggests that BDV might directly modify the epigenetic environment of the chromatin 7 
surrounding the sites of the viral RNP to ensure efficient viral genome survival or persistent 8 
infection. Further understanding of the infection and replication of BDV on chromatin may 9 
provide not only details of a yet unexplored interaction between viruses and eukaryotic cells, 10 
but also alternative mechanisms of the pathogenesis of an animal RNA virus. 11 
 12 
 13 
EXPERIMENTAL PROCEDURES 14 
Cell lines and virus  15 
The OL cell line, derived from a human oligodendroglioma, was cultured in Dulbecco's 16 
modified Eagle's medium (DMEM)-high glucose (4.5%) supplemented with 5% fetal bovine 17 
serum (FBS) and 4 mM glutamine. HEK293T (293T; human embryonic kidney), Vero 18 
(African green monkey kidney) and C6 (rat glioma) cells were cultured in DMEM-low 19 
glucose (1.0%) supplemented with 5% FBS. BDV-infected OL cells, a cell line persistently 20 
infected with strain huP2br (Nakamura et al., 2000), were cultured using the same conditions 21 
as the parental cell line. The shRNA expression cell clones were cultured in DMEM-high 22 
 20 
glucose supplemented with 2 µg/ml puromycin.  1 
 2 
Correlative FM-EM  3 
For observation by FM-EM, BDV-infected and -uninfected OL cells were cultured on gridded, 4 
35 mm glass-bottom dishes (Mat Tek) in 1 ml of DMEM at 37°C overnight. Cells on the grid 5 
were fixed and stained with the specific antibodies as described above and then examined 6 
using a confocal laser scanning microscope. The same specimens were then further incubated 7 
with 2.5% glutaraldehyde and 2% formaldehyde in PBS at 4°C overnight. After three 8 
washings with PBS, the samples were post-fixed with 1% osmium tetroxide and 0.5% 9 
potassium ferrocyanide in PBS for 1 h, washed with distilled water three times, dehydrated in 10 
ethanol, and embedded in Epon812 (Structure Probe). Ultrathin sections of the cell (70-nm 11 
thick) were stained with saturated uranyl acetate and Reynolds lead citrate solution. The 12 
electron micrographs were taken with a JEOL JEM-1011 transmission electron microscope 13 
(JEOL, Ltd.). 14 
 15 
Chromatin isolation  16 
To isolate chromatin, cells (1×107 cells) were resuspended in 300 µl buffer A (10 mM HEPES, 17 
pH 7.9, 10 mM KCl, 1.5 mM MgCl2, 0.34 M sucrose, 10% glycerol, 1 mM DTT, complete 18 
protease inhibitor [Roche]) containing 0.1% Triton X-100. After incubation for 10 min on ice, 19 
nuclei were collected in a pellet by centrifugation (5 min, 1,200 × g, 4°C). Nuclei were 20 
washed three times with buffer A and lysed in buffer B (3 mM EDTA, 0.2 mM EGTA, 1 mM 21 
DTT, complete protease inhibitor) for 30 min on ice. The chromatin enriched pellet was 22 
 21 
collected by centrifugation (5 min, 1,700 × g, 4°C) and the supernatant was removed to yield 1 
a nucleosolic fraction. The pellet was washed twice with buffer B and once with MNase 2 
buffer (10 mM Tris-HCl, pH 8.0, 5 mM NaCl, 2.5 mM CaCl2) and resuspended in 200 µl 3 
MNase buffer containing 20 U MNase. After incubation for 5 min at 37°C, the MNase 4 
reaction was stopped by the addition of an EDTA-EGTA solution to a final concentration of 5 5 
mM, and then the supernatant was collected by centrifugation (5 min, 2,000 × g, 4°C) as a 6 
chromatin-binding fraction. The pellet was washed three times with MNase buffer and 7 
collected as an insoluble fraction. To separate the chromatin into euchromatin and 8 
heterochromatin, nucleic were resuspended in 200 µl buffer A containing 2.5 mM CaCl2 and 9 
20 U MNase and incubated for 4 min at 37°C. After centrifugation (5 min, 5,000 × g, 4°C), 10 
the supernatant was removed to yield a euchromatin fraction. The pellet was washed three 11 
times and then lysed with 200 µl buffer B for 15 min on ice. After centrifugation (5 min, 12 
5,000 × g, 4°C), the supernatant was removed to yield a heterochromatin fraction.  13 
 14 
FRAP and FLIP assays  15 
Cells grown on 35 mm diameter glass-base dishes were transfected with EGFP fused HMGB1 16 
or BDV N with LipofectamineTM 2000 (Invitrogen). At 20-28 h post-transfection, the 17 
medium was replaced with pre-warmed alpha-MEM (Gibco). Photobleaching experiments 18 
were carried out with a Digital Eclipse Spectral Imaging Confocal Laser Microscope C1si 19 
(Nikon Inc.). FRAP assays were done with a confocal laser-scanning microscope FV1000 20 
(Olympus Inc.) using the 473-nm laser line of a semiconductor laser. Briefly, three pre-bleach 21 
images were acquired, followed by a single bleach pulse of 450 ms using a 1.4 µm diameter 22 
 22 
beam spot. Single images were then collected with a 0.57 s interval. The laser power was set 1 
to 5% for imaging and 90% for bleaching. Total fluorescence was determined for each image 2 
and compared to the initial total fluorescence to determine the amount of fluorescence lost 3 
during bleaching and imaging. The fluorescence intensity in the bleached area was normalized 4 
to the initial fluorescence in the bleached area. Each experiment was repeated at least three 5 
times, each of which involved observation of at least 15 independent cells. 6 
 7 
shRNA expression 8 
Lentivirus plasmids for shRNA expression (pLKO.1puro) were purchased from 9 
Sigma-Aldrich. Five independent shRNA sequences for HMGB1 were determined from a 10 
lentiviral vector-based shRNA library, Mission shRNA (Sigma-Aldrich). To generate shRNA 11 
expression lentiviral vectors, plasmids were co-transfected into 293T cells and the medium 12 
was changed 24 h post-transfection. Culture supernatants containing lentiviral vectors were 13 
collected at 48 h post-transfection, filtered through a 0.45-μm filter. To determine the titer of 14 
lentiviral vectors, OL cells were infected with serial dilutions of the viruses, cells were 15 
selected with puromycin, and the number of colonies was counted. To establish 16 
HMGB1-knockdown, BDV-infected cell lines, Hmg-Kd1, Hmg-Kd2 and Hmg-Kd3, BDV 17 
persistently infected OL cells were infected with lentiviral vectors encoding shRNA for 18 
HMGB1. The lentivirus vector-infected cells were selected with puromycin and cloned by 19 
limiting dilution. After establishment of HMGB1-knockdown, BDV persistently infected cell 20 
lines, the infectious ratio and the levels of viral RNAs were monitored by 21 
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Figure legends 1 
 2 
Figure 1.  BDV assembles spherical viral factories supported by chromatin structure.  3 
(A) Confocal microscopic analysis of an interphase nucleus of BDV-infected and uninfected 4 
OL cells. BDV generates vSPOT (arrows) and granular speckles (arrowheads) in the nucleus. 5 
Cells were visualized by anti-BDV N (red) and anti-BDV P (green) antibodies and DAPI 6 
(blue). Magnifications of the boxed areas (1 and 2) are shown on the right. Scale bar, 5 μm. 7 
(B) A detailed structure of vSPOT. A maximum z projection of 33 vertical slices (x-z plane) is 8 
shown. The intensity profiles at dashed lines are indicated at the right. Red, BDV N; Blue, 9 
DAPI. Scale bar, 1 μm. (C) Fluorescence in situ hybridization of the viral genome and 10 
antigenomic RNAs in the nuclei of BDV-infected and uninfected OL cells. Scale bar, 5 μm. 11 
Magnifications of the boxed areas (1 and 2) are shown on the right. (D) Distribution of vRNA 12 
in vSPOT. Immuno-RNA fluorescence in situ hybridization using BDV N antibody (red) and 13 
riboprobe specific for BDV vRNA (green) was performed and analyzed by confocal 14 
microscopy. A maximum z projection of 33 vertical slices (x-z plane) is shown. Scale bar, 1 15 
μm. 16 
 17 
Figure 2.  Correlative FM-EM and immuno-EM analyses of interphase nuclei of 18 
BDV-infected cells. 19 
(A and B) BDV-infected and uninfected OL cells stained by anti-N antibody (red) and DAPI 20 
(blue) were analyzed by immunofluorescence microscopy and the same fields were analyzed 21 
under EM. Serial section (90 nm) analysis was performed for EM observation (B). 22 
 31 
Magnifications of the boxed areas are shown. Arrowheads indicate high electron-dense 1 
heterochromatin territories. Arrows in panels 3 and 4 of (A) indicate twisted and helical 2 
structures in vSPOT and perichromatin-like fibrils connecting between vSPOT and condensed 3 
heterochromatin, respectively. V and Hc indicate vSPOT and heterochromatin areas, 4 
respectively. Scale bars are indicated. (C and D) Immuno-EM images of vSPOT (C) and 5 
granular speckles (D) in BDV-infected and uninfected cells stained with anti-BDV N antibody. 6 
The dark signals are the result of gold labeling. BDV N localizes to the rim of vSPOT (C) and 7 
in association with condensed heterochromatin (D, arrow). A magnification of boxed area is 8 
shown in the right panel (D). Hc, heterochromatin. Scale bars are indicated. See also Figure 9 
S1. 10 
 11 
Figure 3.  BDV is segregated into daughter cell nuclei along with mitotic chromosomes. 12 
(A) The mitotic stages of BDV-infected OL cells were stained by anti-BDV N (red) and 13 
anti-BDV P (green) and DAPI (blue) and analyzed by confocal microscopy. Maximum z 14 
projections of 36 vertical slices (z-y plane) at dashed lines and higher magnification of the 15 
boxed areas are shown on the right. Scale bar, 5 μm. (B) Fluorescence in situ hybridization of 16 
the viral genome RNA on the metaphase chromatin of BDV-infected and uninfected OL cells. 17 
Scale bar, 5 μm. See also Figure S2. 18 
 19 
Figure 4.  Correlative FM-EM and immuno-EM analyses of mitotic chromosomes of 20 
BDV-infected cells. 21 
(A) Metaphase chromosomes of BDV-infected and uninfected cells were stained by anti-N 22 
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antibody (red) and DAPI (blue) and examined by immunofluorescence microscopy. The same 1 
fields were then analyzed by EM. Arrowheads (a to d) indicate the condensed chromatin 2 
fibers. Magnifications of the boxed are shown. Scale bars in panels a to d are 200 nm. (B) 3 
Immuno-EM analysis of metaphase chromosomes of BDV-infected and uninfected cells 4 
stained with anti-BDV N antibody. The dark granular signals are the result of gold labeling. 5 
BDV N localizes on the condensed metaphase chromosomes (arrowheads). Magnifications of 6 
pointed signals are shown. Scale bars in panel 2 and 3 are 200 and 500 nm, respectively. (C) 7 
Anaphase chromosomes of BDV-infected cells were stained by anti-N antibody (red) and 8 
DAPI (blue) and examined by immunofluorescence microscopy. The same fields were then 9 
analyzed by EM. Magnifications of the boxed and pointed area are shown. Arrowheads 10 
indicate the high electron-dense structures on mitotic chromosomes. (D) Immuno-EM 11 
analysis of anaphase chromosomes of BDV-infected cells stained with anti-BDV N antibody. 12 
The dark granular signals are the result of gold labeling. BDV N localizes on the condensed 13 
metaphase chromosomes. Magnifications of boxed areas are shown. Scale bar in panel 2, 200 14 
nm. See also Figure S3 15 
 16 
Figure 5.  Replication-competent BDV RNP interacts with chromatin throughout the 17 
cell cycle.  18 
(A) Chromatin binding assay of BDV RNP in asynchronous and metaphase-arrested infected 19 
cells. BDV N, P and vRNA were detected in the MNase-treated (+) and untreated (-) fractions 20 
by western blotting (BDV N and P, ORC2 and Mek2) or RT-PCR (vRNA). ORC2 21 
(chromatin-associated human protein) and Mek2 (cytosolic kinase) were used as controls for 22 
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the fractionation. (B) BDV P associates with chromatin only through the interaction with N. 1 
The OL cells were cotransfected with expression plasmids of N, TAP-N and P with indicated 2 
combinations. Forty-eight hours posttransfection, western blot analyses were performed with 3 
whole cell lysates or chromatin-bound fraction using BDV N and P antibodies. (C) RNP 4 
isolated from chromatin-binding fractions of uninfected (a) or BDV-infected (b) 5 
asynchronous and metaphase-arrested OL cells were transfected into C6 or Vero cells and 6 
BDV replication was detected by staining with anti-BDV P antibody (green). The inset shows 7 
a 2 x magnification of infected cells. See also Figure S4 8 
 9 
Figure 6.  Binding of HMGB1 with BDV P may be necessary for efficient BDV 10 
persistence. 11 
(A) Distribution of HMGB1 in the cell nuclei infected with wild-type BDV. BDV-infected OL 12 
cells were stained by anti-N antibody (red), anti-HMGB1 (green) and DAPI (blue) and 13 
examined by immunofluorescence microscopy. Arrows indicate vSPOT. Magnifications of the 14 
boxed area are shown. Scale bar corresponds to 5 μm. (B) FRAP and FLIP analyses of 15 
EGFP-fused HMGB1 and BDV N. BDV-infected OL cells expressing EGFP-fused HMGB1 16 
and BDV N were imaged before (t = 0) and during FRAP or FLIP of a vSPOT in the nucleus. 17 
Images were taken at the times (s) indicated. Arrows in pre-bleaching images (t = 0) indicate 18 
the vSPOTs that were bleached. The bleached spots are indicated by white circles. Images 19 
were collected with a 0.57 to 0.60 s interval. Scale bar, 5 μm. (C) HMGB1 is specifically 20 
incorporated into vSPOT by binding to BDV P. Distribution of HMGB1 in the cell nuclei 21 
infected with wild-type BDV (upper panels) and recombinant BDV (rBDV E84N) (lower 22 
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panels), which contains a single amino acid mutation in the binding site of P with to HMGB1. 1 
Cells were stained by anti-P antibody (red) and anti-HMGB1 (green). Arrows indicate vSPOT. 2 
Magnifications of the boxed area are shown. Scale bar corresponds to 5 μm. (D and E) Rescue 3 
of rBDVs encoding P mutant by reverse genetics system. BDV protein (D) and transcription 4 
(E) were detected by western and northern blotting in Vero cells producing wild-type (wt) or 5 
mutant rBDVs (E84Q and E84N), respectively. (F) Partial recovery of HMGB1 binding of 6 
P-E84N by substitution of amino acid 77 with glutamate. BDV P mutant harboring the double 7 
mutation K77E and E84N (P-77E/84) was test in the mammalian two-hybrid system for its 8 
efficiency to bind to rat HMGB1. Error bars represent + SD. See also Figure S5 9 
 10 
Figure 7.  HMGB1 is involved in BDV RNP dynamics on chromatin.  11 
(A) HMGB1 was transiently downregulated by transfection with HMGB1-specific siRNA 12 
(siHMG) or by infection with lentiviral vectors encoding HMGB1-specific shRNAs (shHMG) 13 
in BDV-infected OL cells. Ctrl-siRNA and Ctrl-shRNA denote cells treated with scrambled 14 
control siRNA and shRNA, respectively. Nt denotes non-treated, BDV-infected cells. shHMG 15 
+ Empty and + Escape denote shRNA-HMGB1-knockdown cells transfected with an empty 16 
plasmid or with a plasmid encoding an shRNA-escape mutant of HMGB1, respectively. The 17 
levels of chromatin-associated BDV N and P, as well as total cellular levels of HMGB1, were 18 
determined by western blotting. Core histones were visualized by Coomassie blue as an 19 
internal control of the input chromatin-binding fractions. For HMGB1 knockdown by shRNA, 20 
two independent lentiviral vectors that encode different shRNA sequences were co-infected 21 
into BDV persistently infected OL cells. (B) HMGB1 knockdown did not change the total 22 
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cellular level of P. The expression of HMGB1 and BDV proteins was detected in the total 1 
lysate of the cells transfected siHMGB1 by western blotting. The asterisk indicates a 2 
non-specific band. Tubulin is used as an internal control. (C) The infection ratio of BDV after 3 
the knockdown of HMGB1 in BDV persistently infected cells. The infection ratios of 4 
HMGB1-knockdown, BDV-infected OL cell lines (Hmg-Kd1, -Kd2 and -Kd3) were 5 
monitored by immunofluorescence assay using anti-N antibody at the indicated days after the 6 
establishment of each knockdown cell line. The infection ratios of the first monitoring point 7 
(day 0) are indicated as 1.0 in each knockdown cell line. (D) The relative amount of BDV 8 
mRNA to vRNA in three independent HMGB1-knockdown cell lines (Hmg-Kd1, -Kd2 and 9 
-Kd3). The levels of BDV P mRNA and vRNA were analyzed by qRT-PCR analysis at the 10 
indicate times and the rates of BDV mRNA to vRNA were determined. (C and D) * p < 0.05, 11 
** p < 0.01. n.s., no significance. Error bars represent +/- SD. (E) Stability of 12 
chromatin-associated BDV N in the presence or absence of HMGB1 was determined by 13 
pulse-chase assays. Th(N) denotes the N half-life (mean ± standard deviation of three 14 
independent experiments). Core histones were visualized by Coomassie blue as an internal 15 
control of the input chromatin-binding fractions. (F) Immunofluorescence analysis of 16 
anaphase chromosomes of BDV-infected OL cells showed that HMGB1-knockdown 17 
abrogated the association of BDV RNPs with separating chromosomes. Two independent of 18 
Ctrl-shRNA and Hmg-Kd2 cells are shown. Insets contain a 2.5 x magnification of chromatin 19 
areas. Blue indicates DAPI staining of nuclei. Scale bar, 5 μm. See also Figure S6 20 
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SUPPLEMENTAL EXPERIMENTAL PROCEDURES 
 
Plasmids   
The enhanced green fluorescent protein (EGFP)-fused eukaryotic expression vectors 
(pEGFP-N and pEGFP-HMGB1) used for FRAP and FLIP analyses were constructed as 
previously described (Kobayashi et al., 2001; Pallier et al., 2003; Yanai et al., 2006). The 
tandem tagged BDV N expression vector used for TAP analysis was generated as follows. 
BDV cDNA corresponding to the BDV N ORF was amplified using pcDL-N.wild as template. 
The PCR product was digested with EcoR I and Xho I and cloned into the vector for the TAP 
assay (kindly gift of Dr. Matsuura, Osaka University), to produce pTAP-N. The expression 
plasmid shRNA-resistant HMGB1 cDNA (HMGB1-Escape) was generated with no amino 
acid substitutions by introducing 16 nucleotide substitutions into two independent HMGB1 
shRNA-target sites by PCR-based mutagenesis. Detailed information about the primers and 
PCR procedures used to generate these plasmids is available from the authors. The nucleotide 
sequences of the recombinant plasmids were confirmed by DNA sequence analysis. 
 
Indirect immunofluorescence assays and microscopy   
Cells were plated on Lab-Tek 2 chamber slides (Nalgene Nunc), fixed with 4% 
paraformaldehyde, and permeabilized for 5 min at room temperature with phosphate buffered 
saline (PBS) containing 0.4% Triton X-100. The cells were then incubated with antibodies 
(anti-BDV antibodies [Kobayashi et al., 2003; Watanabe et al., 2000], anti-HMGB1 antibody 
[BD Bioscience], anti-PARP1 polyclonal antibody [Active motif]) for 30 min in a humidified 
chamber at 37°C. This was followed by incubation with appropriate Alexa Fluor-conjugated 
secondary antibodies (Invitrogen). The cells were counterstained with 
4’,6’-diamidino-2-phenylindole (DAPI) for 1 min at room temperature in PBS. For cell 
immunofluorescence imaging, an epifluorescence microscope E600 (Nikon Inc.) or a confocal 
laser-scanning microscope FV1000 (Olympus Inc.) was used for data collection.  
 
FISH 
Riboprobes for FISH were synthesized by using T7 RNA polymerase and DIG RNA labeling 
mix (Roche Diagnostics) according to the manufacturer's instructions. BDV-infected and 
-uninfected OL cells grown on slide glass (Matsunami glass Inc.) were fixed with 4% 
paraformaldehyde, and proteins were then denatured with 0.1 N HCl for 15 min. The cells 
3 
 
were then permeabilized with PBS containing 0.25% Triton X-100 for 5 min, washed with 
PBS, and endogenous peroxidase was inactivated with 0.5% H5IO6 in PBS for 10 min. For 
mitotic cells, the samples were treated with Proteinase K for 10 min at 37°C. After a wash 
with 2 × SSC (0.3 M NaCl-30 mM sodium citrate, pH 7.0), cells were incubated for 30 min at 
37°C in hybridization buffer (50% formamide, 3 × SSC, 5 × Denhardt's solution [Nacalai 
Tesque Inc.], 250 μg/ml salmon sperm DNA [Invitrogen]), followed by a 15-h hybridization 
in hybridization buffer containing the denatured RNA probe at a concentration of 0.5 μg/ml at 
37°C. The cells were then washed with 4 × SSC, 2 × SSC containing 2 µg/ml RNase A 
(Roche Diagnostics), and 0.2 × SSC. Fluorescence signal was detected by using 
anti-DIG-POD antibody (Roche Diagnostics) and TSATM-Plus Fluorescein System 
(PerkinElmer Inc.) according to the manufacturer's instructions. 
 
TAP assay   
A tandem affinity purification (TAP) assay was performed with chromatin-binding fractions 
derived from BDV-infected and uninfected OL cells transfected with pTAP-N. At 48 h 
post-transfection, a chromatin fraction was prepared and lysed with 0.1% Triton X-100 on ice 
for 30 min. After centrifugation, the soluble fraction was immunoprecipitated with anti-HA 
resin (Sigma-Aldrich) for 4 h at 4°C. The resin was washed three times with TNE buffer (10 
mM Tris-HCl, pH 8.0, 150 mM NaCl, 1 mM EDTA, 0.1% Nonidet P-40 [NP-40], complete 
protease inhibitor) and the tagged protein was released from the resin by digestion with 
AcTEV protease (Invitrogen) in 150 µl of TEV buffer containing 10 U protease for 3 h at 
16°C. TNE buffer was added to the supernatant from the centrifugation to increase the volume 
to 500 µl and the preparation was immunoprecipitated with anti-Flag M2 resin 
(Sigma-Aldrich) overnight at 4°C. After washing three times with TNE buffer, the resin was 
incubated with elution buffer (50mM Tris-HCl, pH 7.4, 150mM NaCl, complete protease 
inhibitor) containing 300 ng/µl of 3x Flag peptide (Sigma-Aldrich) for 90 min at 4°C. The 
eluates were analyzed by SDS-PAGE and visualized by silver staining (Wako). The protein 
bands of interest were excised, digested in-gel with trypsin, and analyzed by nanocapillary 
reversed-phase LC-MS/MS using a C18 column (φ 75 µm) on a nanoLC system (Ultimate, 
LC Packing) coupled to a quadrupole time-of-flight mass spectrometer (QTOF Ultima, 
Waters). Direct injection data-dependent acquisition was performed using one MS channel for 
every three MS/MS channels and dynamic exclusion for selected ions. Proteins were 




Immunoprecipitation   
Chromatin-binding fractions prepared from BDV-infected OL cells were lysed with 0.1% 
Triton X-100 on ice for 30 min and clarified by centrifugation for 10 min at 15,000 rpm. 
MNase buffer containing 5 mM EDTA-EGTA and 0.1% Triton X-100 was added to the 
supernatants to increase the volumes to 500 μL and they were incubated overnight with 
Protein-A Sepharose CL-4B (GE Healthcare Science), pre-coated with polyclonal antibody 
against BDV N. After washing three times with TNE buffer, the immunoprecipitates were 
eluted with elution buffer (50 mM glycine, pH 2.5) and analyzed by SDS-PAGE. For 
immunoprecipitation of H2A, H2B, Orc2 and Mek2, the following antibodies were used: 
anti-H2A and -H2B polyclonal antibodies (Upstate, 07-146 and 07-371), anti-Orc2 polyclonal 
antibody (BD Bioscience, 559266), anti-Mek2 antibody (Cell Signaling, 9125).  
 
Quantitative real-time RT-PCR   
Chromatin-bound vRNA was extracted from the chromatin-binding fractions described above 
and reverse transcribed with a Transcriptor First Strand cDNA Synthesis Kit (Roche) using a 
BDV-specific primer (5’-TGT TGC GCT AAC AAC AAA CCA ATC AC-3’) or an anchored 
oligo(dT) primer. Quantitative real-time RT-PCR assays were carried out using a 
gene-specific double fluorescent-labeled probe in the 7900HT Fast Real-Time PCR System 
(Applied Biosystems). The Taqman® probe was labeled with 6-carboxy fluorescein (FAM) as 
the 5’ fluorescent reporter and tetramethylrhodamine (TAMRA) as the 3’ quencher. The 
primers and probe used were as follows: BDV P-forward primer, 5’-ATG CAT TGA CCC 
AAC CAG TC-3’; BDV P-reverse primer, 5’-ATC ATT CGA TAG CTG CTC CCT TC-3’; 
and BDV P-probe, 5’-FAM-AGA ACC CCT CCA TGA TCT CAG ACC CAG A-TAMRA-3’. 
The amount of the first template was measured as follows. The threshold cycle (Ct) value was 
determined as the number of cycles at which a significant fluorescence increase was first 
detected. The threshold was automatically defined by the Sequence Detection System (ABI). 
The Ct-value was converted to signal intensity using a method that assumes the difference of 
1 cycle between samples reflects a 2-fold difference. The relative amounts of BDV vRNA 
between euchromatin and heterochromatin were determined by the correlation with the 





Pulse-chase analysis   
shRNA-expressing or control BDV-infected cells grown on 60 mm diameter dishes were 
washed twice with pre-warmed PBS and starved for 1 h at 37°C in labeling medium 
(Met/Cys-free high glucose DMEM; Gibco). Cells were labeled with 150 µCi 
[35S]methionine/cysteine/ml for 30 min at 37°C and chased for the indicated times in growth 
medium. After the chase, cells were subjected to chromatin-binding assays and then 
immunoprecipitated with anti-BDV N polyclonal antibody as described above. To calculate 
the half-life of chromatin-bound BDV N protein, Th(N), pulse-labeled BDV N was detected 
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Figure S1. Correlative FM-EM and immuno-EM analyses of interphase, BDV-infected
cells. (related to Figure 2)
(A) BDV-infected OL cells stained by anti-N antibody (red) and DAPI (blue) were analyzed by
immunofluorescence microscopy and the same fields were analyzed under EM. (B) Immuno-
EM images of vSPOT in BDV-infected stained with anti-BDV N antibody. A magnification of
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Figure S2. Association of BDV RNP with mitotic chromosomes. (related to Figure 3)
（A）The mitotic stages (metaphase, anaphase and telophase) of BDV-infected OL cells were
stained by anti-BDV N (red) and anti-BDV P (green) and DAPI (blue) and analyzed by
confocal microscopy. Scale bar, 5 μm. (B) The EGFP-fused BDV N expression plasmid was
transfected into OL cells infected with BDV, and the EGFP signal was monitored by
fluorescence microscopy. The metaphase and anaphase nuclei were visualized by DAPI






Figure S3. Serial section correlative FM-EM analyses of metaphase chromosomes of
BDV-infected cells.UHODWHGWR)LJXUH
Metaphase chromosomes of BDV-infected cells were stained by anti-N antibody (red) and
DAPI (blue) and examined by immunofluorescence microscopy. The same fields were then
analyzed by EM. Serial sections (90 nm) were generated for EM observation. Magnifications














































































































Figure S4. BDV RNP associates with chromatin via binding to core histones. (related to
Figure 5)
(A) Salt extraction of BDV RNPs from the chromatin-binding fraction. The nuclei of BDV-
infected OL cells were incubated with buffer A containing 0, 50, 200, 400, and 800 mM NaCl
and extracted for 30 min at 4 ºC. The supernatants, containing proteins released from the nuclei,
were recovered by centrifugation, and western blotting was performed with anti-BDV N and P
polyclonal antibodies. BDV vRNA was detected by RT-PCR using specific primers for BDV
genome RNA. ORC2 (chromatin-associated human protein) and Mek2 (cytosolic kinase) were
used as fractionation controls. Total lysate: total cellular extract of BDV-infected OL cells. (B
and C) Tandem-affinity purification analysis of BDV N. Proteins that co-precipitated with
TAP-N in BDV-infected cells were separated by SDS-PAGE, visualized by silver staining (B),
and identified by western blotting (C). (D) H2B and MNase-resistance vRNA were
immunoprecipitated by anti-N antibody (IP) from the chromatin-binding fractions of
asynchronous and metaphase-arrested BDV-infected OL cells. H2B was detected by western
blotting. Asterisk indicates a non-specific band. Core histones in the input panel were
visualized by Coomassie blue. (E) Distribution of PARP-1 in BDV persistently infected
nucleus. BDV-infected OL cells were stained by anti-PARP-1 (green) and BDV N (red)
antibodies. The nuclei were visualized by DAPI staining. PARP-1 appeared to not colocalize
with vSPOT in the infected nuclei. Magnifications of the boxed area are shown. Scale bar, 5μm.
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Figure S5. FRAP and FLIP analyses of EGFP-HMGB1 and generation of rBDVs that
lack the interaction with HMGB1. (related to Figure 6)
(A) BDV-infected and uninfected OL cells expressing EGFP-HMGB1 were imaged before
(t = 0) and during FRAP or FLIP of a chromatin area in the nucleus. Images were taken at
the times (s) indicated. The bleached spots are indicated by white circles. Scale bar, 5 μm.
(B) BDV P mutants with the indicated amino acid substitution in the HMGB1 binding
region were tested for efficient protein-protein interaction with viral nucleocapsid protein
(nucleoprotein [N], X protein [X] and wt P [P]) and rat HMGB1 in the mammalian-two
hybrid (MTH) system and for their activity in the BDV minireplicon assay (MR). (+)
unimpaired activity compared to wt P, (-) less than 3% activity compared to wt P. (C) The
efficiency of BDV P mutants to bind rat HMGB1 in vitro were analyzed in an pull-down
assay using E. coli purified histidine-tagged P mutants and N bound to Ni-agarose beads
(upper panel). Bound material was analyzed by immunoblotting (IB) using anti-Flag
antibodies. Note that in contrast to N, residual HMGB1 remains bound to the P mutants. CE,
cell extract. (D) The rBDVs rescued by reverse genetics system in Vero cells were
cocultured with puromycin-resistant OL cells, and three days after the co-culture, the
selection with puromycin was added to the culture. The propagation of rBDVs (wild-type,
E84N, and E84Q) were monitored by immunofluorescence assay using anti-N antibody at


































































































Figure S6. BDV dynamics in the nucleus of HMGB1-knockdown cells. (related to Figure
7)
(A) BDV-infected OL cells were infected with lentiviral vectors that encode shRNAs for
HMGB1, and shRNA expression cells were selected by puromycin resistance. Two
independent shRNAs were used for the knockdown. IFA for three different cell lines (Hmg-
Kd1, -Kd2, and -Kd3) are shown. The cell lines were strained with anti-HMGB1 (red) and
anti-BDV N (green) antibodies. Nt denotes non-treated BDV-infected cells. Ctrl-shRNA
denotes cells treated with scrambled control shRNA. Hmg-Kd1 showed a mild knockdown of
HMGB1 (< 70% based on the fluorescence intensity), whereas Hmg-Kd2 and -Kd3 showed a
significant reduction of HMGB1 (< 90%). (B) Structure of vSPOT in HMGB1-kockdown,
BDV-infected cells. Immunofluorescence analysis of HMGB1-knockdown (Hmg-Kd2) and
Ctrl-shRNA-treated OL cells were performed with anti-BDV N (red) and HMGB1 (green)
antibodies. Scale bar, 5 μm. Magnifications and detailed 3D structures of the boxed vSPOTs
are shown on the right (Scale bar, 1 μm). A maximum z projection of 33 vertical slices (x-z
plane) is shown. (C and D) BDV minireplicon assay using 293T cells treated with siRNA for
HMGB1. Twenty-four hour after the transfection of siRNAs, 293T cells were transfected with
BDV minireplicon plasmids, and 48 h later CAT activity in cell lysates was determined with
the CAT-ELISA system (C). Relative CAT level from three independent experiments are
expressed as mean plus SD. *p < 0.05. The expression of HMGB1 in the cells treated with ctrl-
siRNA and siHMGB1 were detected by western blotting at 48 h posttransfection of
minireplicon constructs. (E and F) Dissociation of BDV RNP from mitotic chromosomes in
HMGB1-knockdown, BDV-infected cells. Immunofluorescence analysis of metaphase (E) and
anaphase (F) of HMGB1-knockdown, BDV-infected (Hmg-Kd1, -Kd2, and -Kd3) and Ctrl-
shRNA-treated, BDV-infected OL cell nuclei. The cells were stained with anti-BDV N
antibody (red). The nuclei were visualized by DAPI staining. Magnifications and the numbered
cells are shown on the right. HMGB1-knockdown appeared to abrogate the association of BDV
RNPs with mitotic chromosomes. Scale bar, 5 μm.
